单吻合口胃旁路术作为初次减重手术:MBSAQIP数据库短期安全性与结局分析
基于MBSAQIP 2020至2021年数据库,比较初次单吻合口胃旁路术(OAGB)与Roux-en-Y胃旁路术(RYGB)及袖状胃切除联合单吻合口十二指肠回肠旁路术(SADI-S)的30天结局。OAGB住院时间、手术时间更短,总体并发症、输血、非计划ICU入住、再入院及再手术率更低;多因素回归显示RYGB和SADI-S的30天并发症几率更高。
要点
- OAGB住院时间1.39±1.10天,短于RYGB的1.62±1.42天和SADI-S的1.90±2.04天。
- OAGB总体并发症率1.9%,低于RYGB的4.5%和SADI-S的6.4%。
- 多因素回归显示RYGB和SADI-S的30天并发症几率高于OAGB。
核心结论
- 自ASMBS批准后,初次OAGB占比从2015至2019年的0.05%升至2020至2021年的0.78%。
- OAGB的30天结局优于RYGB和SADI-S且手术时间更短,因此可被视为可行的替代方案。
研究设计与样本
- 利用MBSAQIP 2020和2021年数据库识别接受初次OAGB、RYGB和SADI-S的患者。
- 比较三种旁路手术的患者人口学特征和30天结局,并行多因素logistic回归分析总体并发症、输血、非计划ICU入住、再入院、再手术和吻合口漏。
- 2020至2021年间共报告1607例初次OAGB。
主要发现
- RYGB和SADI-S患者合并症发生率更高。
- OAGB住院时间1.39±1.10天,RYGB为1.62±1.42天,SADI-S为1.90±2.04天。
- OAGB手术时间98.79±52.76分钟,RYGB为125.91±57.76分钟,SADI-S为139.85±59.20分钟。
- OAGB总体并发症率1.9%,RYGB为4.5%,SADI-S为6.4%;输血率0.4% vs 1.1%和1.8%;非计划ICU入住率0.3% vs 0.8%和1.4%;再入院率2.4% vs 4.9%和5.0%;再手术率1.2% vs 1.9%和3.1%。
- 多因素logistic回归分析显示,RYGB和SADI-S的30天并发症几率高于OAGB。
临床怎么用
- 原文结论认为OAGB可被视为可行的替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One anastomosis gastric bypass (OAGB) is described as a simpler, potentially safe, and effective bariatric-metabolic procedure that has been recently endorsed by the American Society of Metabolic and Bariatric Surgery. OBJECTIVES: First, we aim to compare the 30-day outcomes between OAGB and other bypass procedures: Roux-en-Y gastric bypass (RYGB) and single anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S). Second, identify the odds between postoperative complications and each surgical procedure. METHODS: Patients who underwent primary OAGB, RYGB, and SADI-S were identified using the MBSAQIP database of 2020 and 2021. An analysis of patient demographics and 30-day outcomes were compared between these three bypass procedures. In addition, a multilogistic regression for overall complications, blood transfusions, unplanned ICU admissions, readmission, reoperation, and anastomotic leak stratified by surgical procedure was performed. RESULTS: 1607 primary OAGBs were reported between 2020 and 2021. In terms of patient demographics, patients who underwent RYGB and SADI-S showed a higher incidence of comorbidities. On the other hand, OAGB had shorter length of stay (1.39 ± 1.10 days vs 1.62 ± 1.42 days and 1.90 ± 2.04 days) and operative times (98.79 ± 52.76 min vs 125.91 ± 57.76 min and 139.85 ± 59.20 min) than RYGB and SADI-S. Similarly, OAGB showed lower rates of overall complications (1.9% vs 4.5% and 6.4%), blood transfusions (0.4% vs 1.1% and 1.8%), unplanned ICU admission (0.3% vs 0.8% and 1.4%), readmission (2.4% vs 4.9% and 5.0%), and reoperation (1.2% vs 1.9% and 3.1%). A multilogistic regression analysis was performed, RYGB and SADI-S demonstrated higher odds of 30-day complications. CONCLUSION: The incidence of primary OAGB has increased since its approval by ASMBS, from 0.05% reported between 2015 and 2019 to 0.78% between 2020 and 2021. OAGB had better 30-day outcomes and shorter operative times than RYGB and SADI-S and therefore, could be considered a viable alternative.
引用
- Cornejo J, Evans LA, Castillo-Larios R, et al. One anastomosis gastric bypass as a primary bariatric surgery: MBSAQIP database analysis of short-term safety and outcomes. Surg Endosc. 2023. PMID: 37989890. doi:10.1007/s00464-023-10535-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。